IL10 and familial pancreatic carcinoma: According to a number of studies, an increase in IL-10 levels can dramatically drive tumor proliferation, metastasis, and immune evasion in a range of tumor models, including pancreatic cancer, and hence result in diverse pathologies (Zhuang et al., 2019).